Philips Medical Systems Incurs Second Warning Letter Since August
This article was originally published in The Gray Sheet
Executive Summary
Corrective actions related to a warning letter Philips Medical Systems received Oct. 16 will be addressed during a meeting between the company and FDA the week of Nov. 3
You may also be interested in...
Philips Intera MR Subject Of Warning Letter For Unapproved Perfusion Claim
FDA's recent warning letter to Philips Medical regarding promotion of magnetic resonance (MR) scanners for cardiac perfusion studies is symptomatic of the industry's struggle to find a regulatory pathway to approval for the indication
Paper Tigers Or Paper Bullets? FDA Curbs Repeat Warning Letters, Violations
Enforcement policies under way within FDA's Office of the Chief Counsel could eliminate the practice of issuing multiple compliance warning letters, according to agency officials
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.